Single-Cell Transcriptional and Epigenetic Profiles of Male Breast Cancer Nominate Salient Cancer-Specific Enhancers.
Single-Cell Transcriptional and Epigenetic Profiles of Male Breast Cancer Nominate Salient Cancer-Specific Enhancers.
复制标题
男性乳腺癌的单细胞转录和表观遗传学特征提名了明显的癌症特异性增强子。
DOI:
10.3390/ijms241713053
复制
发表时间:
2023-08-22
影响因子:
5.6
通讯作者:
Franco, Hector L.
中科院分区:
文献类型:
--
作者:
Kim, Hyunsoo;Wisniewska, Kamila;Regner, Matthew J.;Thennavan, Aatish;Spanheimer, Philip M.;Franco, Hector L.
关键词:
Male breast cancer represents about 1% of all breast cancer diagnoses and, although there are some similarities between male and female breast cancer, the paucity of data available on male breast cancer makes it difficult to establish targeted therapies. To date, most male breast cancers (MBCs) are treated according to protocols established for female breast cancer (FBC). Thus, defining the transcriptional and epigenetic landscape of MBC with improved resolution is critical for developing better avenues for therapeutic intervention. In this study, we present matched transcriptional (scRNA-seq) and epigenetic (scATAC-seq) profiles at single-cell resolution of two treatment naïve MBC tumors processed immediately after surgical resection. These data enable the detection of differentially expressed genes between male and female breast tumors across immune, stromal, and malignant cell types, to highlight several genes that may have therapeutic implications. Notably, MYC target genes and mTORC1 signaling genes were significantly upregulated in the malignant cells of MBC compared to the female counterparts. To understand how the regulatory landscape of MBC gives rise to these male-specific gene expression patterns, we leveraged the scATAC-seq data to systematically link changes in chromatin accessibility to changes in gene expression within each cell type. We observed cancer-specific rewiring of several salient enhancers and posit that these enhancers have a higher regulatory load than lineage-specific enhancers. We highlight two examples of previously unannotated cancer-cell-specific enhancers of ANXA2 and PRDX4 gene expression and show evidence for super-enhancer regulation of LAMB3 and CD47 in male breast cancer cells. Overall, this dataset annotates clinically relevant regulatory networks in male breast tumors, providing a useful resource that expands our current understanding of the gene expression programs that underlie the biology of MBC.
登录
查看更多内容
影响因子:
8
作者:
Cassandri, Matteo;Butera, Alessio;Melino, Gerry
通讯作者:
Melino, Gerry
影响因子:
14.9
作者:
Bailey TL;Johnson J;Grant CE;Noble WS
通讯作者:
Noble WS
影响因子:
64.8
作者:
Buenrostro JD;Wu B;Litzenburger UM;Ruff D;Gonzales ML;Snyder MP;Chang HY;Greenleaf WJ
通讯作者:
Greenleaf WJ
DOI:
10.1111/j.2517-6161.1995.tb02031.x
发表时间:
1995-01-01
影响因子:
5.8
作者:
BENJAMINI, Y;HOCHBERG, Y
通讯作者:
HOCHBERG, Y
影响因子:
3.8
作者:
Gibbs, Lee D.;Chaudhary, Pankaj;Vishwanatha, Jamboor K.
通讯作者:
Vishwanatha, Jamboor K.